Page 577«..1020..576577578579..590600..»

Category Archives: Transhuman News

Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station – Business Wire

Posted: December 22, 2021 at 12:33 am

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) to study the effects of microgravity on human brain physiology as part of the Tissue-Chips in Space initiative sponsored by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the International Space Station National Lab (ISS-NL). The ISS provides an environment where researchers can study human health in microgravity, allowing them to isolate the effects of gravity from other factors that can impact brain cell function.

The Emulate Brain-Chip is the most comprehensive in vitro model of the human neurovascular unit, including the blood-brain barrier (BBB), for preclinical research. It contains five cell types in a dynamic and tunable microenvironment, resulting in in vivo-like gene expression and phenotypic response. Each chip is about the size of a USB thumb drive and contains two fluidic channels separated by a porous membrane. The vascular channel is lined with brain microvascular endothelial cells, while the brain channel contains cortical neurons, astrocytes, pericytes, and microglia. This allows researchers to study BBB function, the ability of drugs to cross the BBB, and the complex cell-cell interactions involved in brain physiology, disease, and drug response.

All 12 chips will be situated in a shoebox-sized piece of instrumentation that was custom designed for spaceflight, which provides automated environmental control, perfusion, fluid sampling, dosing, and fixation as part of the experiment.

Emulates implementation partner, SpaceTango, has an agreement with NASA allowing them to manufacture and deploy commercial payloads to the space station for microgravity research and development. As such, SpaceTango has led the development of the instrumentation and is responsible for overseeing the logistics of sending the Brain-Chip to the ISS.

By comparing the human Brain-Chip response to an inflammatory stimulus under reduced gravity conditions versus its response back on Earth, we will be able to investigate differences in cytokine production, BBB permeability, and morphology, said Daniel Levner, Chief Technology Officer of Emulate. Previous studies, such as NASAs Functional Immune study, have shown changes in endothelial cell morphology in 2D cultures in space as well as many changes in astronaut immune function during spaceflight. Understanding how the immune system interacts with organ biology in microgravity will be important for future research, and we are honored to be a part of this project.

Earlier this year, the Emulate Brain-Chip was honored by The Scientist as one of the Top 10 Innovations of 2021. For more information on Emulate, please visit emulatebio.com.

Research reported in this press release was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UG3TR002188. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About Emulate, Inc.

Emulate is igniting a new era in human health with industry-leading Organ-on-a-Chip technology. The Human Emulation System provides a window into the inner workings of human biology and diseaseoffering researchers an innovative technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Pioneered at the Wyss Institute for Biologically Inspired Engineering at Harvard University and backed by Northpond Ventures, Founders Fund, and Perceptive Advisors, Organ-on-a-Chip technology is assisting researchers across academia, pharma, and government industries through its predictive power and ability to recreate true-to-life human biology. To learn more, visit emulatebio.com or follow us on LinkedIn and Twitter.

Read more here:
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station - Business Wire

Posted in Space Station | Comments Off on Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station – Business Wire

SpaceX to deliver Xmas to space station – The Inverell Times

Posted: at 12:33 am

news, world

SpaceX launched Christmas gifts, goodies and supplies to the International Space Station and got a present in return: the company's 100th successful rocket landing. The pre-dawn liftoff from NASA's Kennedy Space Center on Tuesday was barely visible in the fog and clouds, as the Falcon rocket hoisted a Dragon capsule loaded with nearly 3000 kilograms of gear for the station's seven astronauts. Several minutes later, the first-stage booster landed upright on an ocean platform, six years to the day that Elon Musk's company accomplished its first booster touchdown in 2015. This particular booster was making its first flight. A few days ago, a SpaceX booster made its 11th flight. "It's critical to lower the cost of spaceflight to continue to reuse these boosters more and more times. A hundred is a big milestone, so we're excited about that," said SpaceX's Sarah Walker, a mission manager. "We're also excited to see how few new boosters we have to produce as the years go by." Among the items due to arrive at the space station Wednesday will be: Christmas presents from the astronauts' families, smoked fish and turkey, green beans and fruitcake for a holiday feast. NASA's space station program manager Joel Montalbano wouldn't divulge anything else. "I won't get in front of Santa Claus and tell you what's going to be sent up," he told reporters on the eve of launch. The delivery also includes a laundry detergent experiment. Station astronauts currently trash their dirty clothes; Procter & Gamble Co. is developing a fully degradable detergent for eventual use at the station, on the moon and beyond. SpaceX is ending the year with 31 launches, the most ever by the company. Australian Associated Press

/images/transform/v1/crop/frm/silverstone-feed-data/f301d05b-e583-4e11-8b74-3abbbb0f0ae6.jpg/r0_74_800_526_w1200_h678_fmax.jpg

December 22 2021 - 4:56AM

SpaceX launched Christmas gifts, goodies and supplies to the International Space Station and got a present in return: the company's 100th successful rocket landing.

The pre-dawn liftoff from NASA's Kennedy Space Center on Tuesday was barely visible in the fog and clouds, as the Falcon rocket hoisted a Dragon capsule loaded with nearly 3000 kilograms of gear for the station's seven astronauts.

Several minutes later, the first-stage booster landed upright on an ocean platform, six years to the day that Elon Musk's company accomplished its first booster touchdown in 2015.

This particular booster was making its first flight. A few days ago, a SpaceX booster made its 11th flight.

"It's critical to lower the cost of spaceflight to continue to reuse these boosters more and more times. A hundred is a big milestone, so we're excited about that," said SpaceX's Sarah Walker, a mission manager.

"We're also excited to see how few new boosters we have to produce as the years go by."

Among the items due to arrive at the space station Wednesday will be: Christmas presents from the astronauts' families, smoked fish and turkey, green beans and fruitcake for a holiday feast.

NASA's space station program manager Joel Montalbano wouldn't divulge anything else. "I won't get in front of Santa Claus and tell you what's going to be sent up," he told reporters on the eve of launch.

The delivery also includes a laundry detergent experiment. Station astronauts currently trash their dirty clothes; Procter & Gamble Co. is developing a fully degradable detergent for eventual use at the station, on the moon and beyond.

SpaceX is ending the year with 31 launches, the most ever by the company.

Australian Associated Press

More:
SpaceX to deliver Xmas to space station - The Inverell Times

Posted in Space Station | Comments Off on SpaceX to deliver Xmas to space station – The Inverell Times

The future of omicron variant: Scientists predict whats next – Deseret News

Posted: December 19, 2021 at 7:06 pm

Multiple scientists and experts are weighing on what Americans should expect from the omicron variant of the coronavirus over the next few weeks.

Dr. Stephen Goldstein, professor at the Eccles Institute of Human Genetics at the University of Utah, told Salon that cases will rise in the next few weeks to peak levels.

Dr. Monica Gandhi, infectious disease doctor and professor of medicine at the University of California-San Francisco, told Salon that omicron is more transmissible and will cause a wave of new infections.

Its clear from these comments that the omicron variant is spreading and will continue to do so as we move through winter. Its unclear if the strain is less virulent meaning it causes less severe symptoms on its own or if people are more immune to the coronavirus by now, creating less severe symptoms.

Either way, the Centers for Disease Control and Prevention recently predicted a new surge of omicron cases will impact the U.S. by January 2022, according to The Washington Post.

Continued here:
The future of omicron variant: Scientists predict whats next - Deseret News

Posted in Human Genetics | Comments Off on The future of omicron variant: Scientists predict whats next – Deseret News

Exploring genetics of SARS-CoV-2 and related viruses in animals around the world – EurekAlert

Posted: at 7:06 pm

image:Fig 2. Possible evolution and transmission pathways of SARS-CoV-2 and its related virus at animal-human- ecosystem interface. view more

Credit: Image Credit: Islam et al., 2021, PLOS ONE, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

A genetic and geographic analysis of variants of SARS-CoV-2the virus that causes COVID-19and related viruses in humans and animals may provide evidence of interspecies transmission worldwide. Dr. Ariful Islam, of EcoHealth Alliance and the Bangladesh Institute of Epidemiology, Disease Control and Research, and colleagues present these findings in the open-access journal PLOS ONE on December 15, 2021.

Prior research has suggested that SARS-CoV-2 might have originated through genetic changes that occurred among closely related viruses in horseshoe bats. Reports also suggest that the virus can spread from humans to domesticated and wild animals (known as spillback). However, much remains to be learned about the epidemiology, evolutionary dynamics and genetic relationships between SARS-CoV-2 and related viruses in animals around the world.

To provide new insights, Dr. Islam and colleagues conducted a comprehensive analysis of the genome sequences of SARS-CoV-2-related viruses found in bats and pangolins, and of the SARS-CoV-2 strains that have been found in a variety of animals across the globe, including dogs, cats and lions.

Genetic analysis showed that SARS-CoV-2 strains found in animals are closely related to strains found in humans in the same geographic regions - including Germany, France, Spain, and Denmark - which evidences the theory that human to animal transmission has occurred worldwide. In future, if the virus becomes established in animal hosts, that animal species might act as a SARS-CoV-2 reservoir.

The researchers also quantified the degree to which genetic mutations associated with key SARS-CoV-2 subtypes and variants are found in animal species in different regions. Multiple emerging variants of concern, such as the Alpha, Delta and Mu-variants, were detected across many countries in species including dogs, gorillas, lions, and cats, and these variants showed notable genetic similarity with human SARS-CoV-2 sequences. For example, cats and American mink were frequently infected with one subtype of virus known as the GR clade (31.6% and 49.7% of samples respectively), which is also often seen in humans, supporting the likelihood of interspecies transmission. However, most dogs were affected by a different subtype, clade O (66.7%), which the authors suggest indicates a particular affinity of clade O for dogs. The SARS-CoV-2 Alpha variant comprised just 2.6% of cat and 4.8% of dog samples, but 66.7% of gorilla and 77.3% of lion samples.

Their genetic analysis revealed very high similarity between SARS-CoV-2 and related viruses found in multiple horseshoe bat species, as well as high similarity with related viruses in the Malayan pangolin. The analysis supports the hypothesis that SARS-CoV-2 originated from closely related bat viruses that genetically recombined with each other, and that the virus also passed through pangolins.

Animals appear to be susceptible to SARS-CoV-2 and may contribute to its spread. Thus, on the basis of their findings, the researchers call for continued genetic monitoring of SARS-CoV-2 in animals. They also call for prevention of contact between infected humans and animals, as well as vaccination of pets, zoo animals, and farm animals. The researchers advocate for surveillance at the human-animal interface to detect and prevent emergence of future viruses.

The authors add: Spillover and spillback of SARS-CoV-2 has been proved, and the mutant strain of the virus is still dominating. It is our responsibility not to destroy the natural habitats of wildlife. As bats play an important role in maintaining a healthy ecosystem, we need to work on how to live safely with bats. We should not wait until the next pandemic, and we need to apply the One Health approach to secure a healthier future for the world.

Observational study

Animals

Spatial epidemiology and genetic diversity of SARS-CoV-2 and related coronaviruses in domestic and wild animals

15-Dec-2021

The authors have declared that no competing interests exist.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Link:
Exploring genetics of SARS-CoV-2 and related viruses in animals around the world - EurekAlert

Posted in Human Genetics | Comments Off on Exploring genetics of SARS-CoV-2 and related viruses in animals around the world – EurekAlert

We asked scientists what the omicron variant is going to do to the United States – Salon

Posted: at 7:06 pm

If you want to get a good sense of how the omicron variant of COVID-19 is going to spread in the United States, just look across the ocean.Inthe United Kingdom and South Africatwo nations in which the omicron variant is quickly becoming more dominant than delta, or has already infection rates are surging, largely becausethe variant is so much more transmissible. While current evidence suggests patients stricken with omicronare less likely to require hospitalization or die, huge infection rates have put massive pressure on both nations' infrastructure.

Now that omicron has graced the shores of the United States, we appear to be in the early phases of what the aforementioned countries are experiencing.In New York City, the percentage of people testing positive for COVID-19 doubled in three days this week, with a Mayor Bill de Blasio advisor attributing the spike to the omicron variant.During a Tuesday briefing for the Centers for Disease Control and Prevention (CDC), top federal health officials told reporters that there had been a sevenfold jump in the prevalence of theomicron variant over the course of a single week.

Although the surgecould subside after the spring, they added thatif current trends persistthere may be a public health crisis. This would beespecially so if the delta variant continues to wreak havoc, and aninfluenza epidemic exacerbates the problemcaused by the pair of COVID-19 strains. The former scenario is already occurring and the latter is increasingly plausible, at least based on the timetable that scientists have established for when the omicron variant is likely to surge in the United States.

"Based on data from South Africa and Europe we can expect a significant increase in case numbers here in the US in the next several weeks,"Dr. Stephen Goldstein, professor at the Eccles Institute of Human Genetics at the University of Utah, told Salon by email."It is possibletolikely that peak cases numbers will exceed last winter's peak."

Dr. Georges Benjamin, executive director of the American Public Health Association, predicted that omicron will become the dominant variant in the United States within three to six months.

"This is based on its high degree of infectiousness, the significant number of people unvaccinated and the degree of breakthrough infections for people that are fully vaccinated but un-boosted," Benjamin explained in writing."Breakthrough infections in people that are fully vaccinated and boosteddo occur, but are at a lower rate."

The underlying problem is that the omicron variant is more transmissible than previous variants. When it comes to stopping a pandemic, there are few things that epidemiologistsdread more than a hyper-transmissible bug.

IndeedDr. Russell Medford, chairman of the Center for Global Health Innovation and Global Health Crisis Coordination Center, told Salon by email that he expects the omicron variant to dominate in the United Statesjust as it currently does in the United Kingdombecause "the omicron variant is significantly more transmissible than delta."

Dr. Monica Gandhi, infectious disease doctor and professor of medicine at the University of CaliforniaSan Francisco, also said that the omicron variant is "more transmissibleand will cause a wave of new infections," but added that"there is now evidence that Omicron is less severe than previous strains." What scientists do not yet know, she added, is "if this is because of increasing cellular immunity in the population in December 2021 versus an inherent property of the strain that makes it less virulent."

Want more health and science stories in your inbox? Subscribe toSalon's weekly newsletter The Vulgar Scientist.

Beyond transmissibility, the next-biggest concern with omicron is the question of vaccine resistance. In the past six months, the delta variant's spread was blunted by the number of vaccinated Americans and while delta was faintly vaccine-resistant, the majority of COVID-19 hospitalizations and deaths in the United States were among theunvaccinated, prompting the head of the CDCto dub the situation a "pandemic of the unvaccinated."

Yet omicron may be more vaccine-resistant than delta, primarily for reasons relating to mutations onthe spike protein.B.1.1.529 (the omicron variant's official name) has30 mutations located near the spike protein which is worryingmainly because the mRNAvaccines produced for COVID-19 specifically target it. The spike protein comprises thespikes that jut out from around the SARS-CoV-2 virus'central sphere like spines on a sea urchin. The virus uses those spikes to enter a body's cells, like a pick being used to open a lock, while existingvaccines help one's cells produce proteins like those on the spikes that the immune system produces antibodies against. If the mutations sufficiently alter the spike protein, the body's immune system may be less adept at recognizing the virus, having been prepared to fight a different version of the spike.

"The two vaccinations, typically of any of the vaccines, offervirtually no protection against infection and transmission,"Dr. William Haseltine,founder and former CEO of Human Genome Sciencesandcurrently the chair and president of the global health think tank Access Health International, told Salon."Three vaccinations offeronly very temporaryprotection after three months."

Haseltine also noted that the vaccines were adept at reducing hospitalization and death, perhaps even by as much as tenfold, but"will not eliminate it." And, he added, the vaccines "will notspare those who are infected from you who are not similar protected from the consequences ofthe disease, which can be quite serious." That's because the vaccine is defensive, Haseltine said: it does not stop the virus from entering the body, only fights it once it is inside.

Want more health and science stories in your inbox? Subscribe toSalon's weekly newsletter The Vulgar Scientist.

Goldstein drew attention to a different caveat to the undeniable advantages of pre-existing immunity (whether through vaccination or infection).

"While encouraging on an individual basis, this coming surge will almost certainly produce enough severe infections to overwhelm already stretched healthcare resources," Goldstein pointed out."Double vaccination orprior infection, though they likely blunt severity, will not provide substantial protection from infection and onward transmission of omicron. It is imperative that people get vaccinated and/or boosted as soon as possible to protect themselves from the imminent omicron surge."

Medford seemed more cautiously optimistic in his assessment. He told Salon that the omicron variant was "considerabl[y]more resistant than delta to the neutralizing antibodies generated by our first line mRNA vaccines, and even more so with other vaccine types" andadded that "fortunately, a third dose of the mRNA vaccine, or booster, appears to largely correctthis vaccine resistance." He said he thinks it is likely that the mRNA vaccines remain effective, "especially with a third dose booster," when it comes to preventing hospitalizations and deaths from serious omicron variant infections although he added this has not been formally documented.

When it comes to the long-term consequences of the omicron variant in terms of the COVID-19 pandemic, two of the experts who spoke with Salon used the same word "endemic."

"The pandemic is transiting into aphase where it is endemic," Benjamin told Salon. "This means there will episodic outbreaks that will be managed by contact racing, individual quarantines, targeted closures of activities or events and vaccinations /revaccinations for people that need it. Eventually as the disease becomes less severe/lethal some of these pubic health measures may be relaxed."

Medford had a similar observation.

"COVID-19 variants such as omicron and others in the future will become an endemic feature of this disease akin to seasonal influenza," Medford explained. "The data today with current vaccines are promising in that full vaccination (3 doses) are remain effective even in the face of new and structurally different viral variants."

If COVID-19 truly is going to be endemic, then perhaps policymakers will need to take that into account.Looking forward, Gandhi (who did not use the word "endemic" in her email) suggested that it might be wise for public health officials to base their policies off of hospitalizations rather than infections, given that the omicron variant could lead to a surge of mild cases.

"We are likely to get many cases with omicron worldwide but since the severity of disease is reduced the impact of this variant (and restrictions such as mask mandates and capacity limits) should be based on hospitalization metrics for COVID-19," Gandhi pointed out. "If the omicron variant is that transmissible but causes less severe disease, it is likely to find unvaccinated individuals, leading to more immunity in those populations, and infect even vaccinated individuals, boosting their immunity even further which will hasten more immunity and hopefully make the pandemic calm own worldwide."

Read more:
We asked scientists what the omicron variant is going to do to the United States - Salon

Posted in Human Genetics | Comments Off on We asked scientists what the omicron variant is going to do to the United States – Salon

Advanced gene therapy may reverse hearing loss caused by genetics: study – Fox News

Posted: at 7:06 pm

Researchers at Boston Childrens Hospital found that replacing a mutated protein in the inner ear reversed severe hearing loss in mice, according to a study published in the journal Science Advances. The first-of-its-kind gene therapy technique involved replacing a mutated protein called stereocilin, (STRC), in the inner ear. The investigators said it reversed severe hearing loss in mice and in some cases, restored it to normal levels of hearing, according to a news release.

Closeup of examining ear with an otoscope

The researchers explained in the release, that hearing loss has been associated with mutations of at least 100 different genes. The researchers stated that up to 16 percent of genetic hearing loss could be linked to the gene STRC, which they noted is also the second most common genetic cause.

"Patients who carry STRC mutations lack cochlear amplification entirely and, as a result, suffer from reduced auditory sensitivity and have difficulty with frequency discrimination and speech perception", the authors stated in the published report in the peer-reviewed journal.

In order to hear sound, sensory hair cells in the inner ear need to make contact with the tectorial membrane the researchers reported. The membrane responds to sound by vibrating and converting the vibrations into signals that travel to the brain.

The investigators say the stereocilin protein acts like a scaffold and helps the hair cells stand up in an organized bundle, which allows the hair cell tips to touch the tectorial membrane.

COVID-19 CAN INFECT INNER EAR CELLS, RESEARCHERS SAY

"If stereocilin is mutated, you dont have that contact, so the hair cells are not stimulated properly," Jeffrey Holt, Ph.D., a scientist in the Department of Otolaryngology and Neurology at Boston Childrens, said.

"But importantly, the hair cells still remain functional, so they are receptive to the gene therapy. We think this will provide a broad window of opportunity for treatment from babies to adults with hearing loss," Holt, who is also the studys senior investigator, said in the release.

Tinnitus is not a condition itself, but rather is a sign of one, such as age-related hearing loss, an earwax blockage, or stiffening of the bones of the middle year, according to the Mayo Clinic. (iStock)

Using a generated mouse model, the researchers designed a dual-vector protein-recombination strategy to replace full-length wild-type Strc in the outer hair cells of mice that carry STRC mutations, according to the study. The investigators discovered what they described as "robust restoration of fulllength stereocilin protein" in the mice and noted hair bundles that had a normal appearance and were able to contact the tectorial membrane, according to the report.

The researchers then performed two types of hearing tests. One is often used in babies and another one that used electrodes on the scalp to measure auditory brainstem responses to a range of sound frequencies and intensities.

GROWING EVIDENCE LINKS COVID-19, HEARING LOSS, RESEARCHERS SAY

The study findings revealed the mice were more sensitive to subtle sounds. The Boston team also discovered the mice had improved cochlear amplification, which they described as increased ability to amplify soft sounds, tamp down the response to loud sounds, and more accurately discriminate between sounds of different frequencies. Hearing was restored to normal levels in some mice, according to the release.

The man listens attentively with her palm to her ear, close up (Credit: iStock)

"The results were remarkable and are the first example of hearing restoration using dual-vector gene therapy to target sensory outer hair cells," said Olga Shubina-Oleinik, PhD who is the studys first author. Eliot Shearer, MD, PhD, who is a co-author of the study and worked with the Childrens Rare Disease Cohort Initiative to screen a large genomic data set for STRC mutations, said in a release, that 2.3 million people worldwide carry STRC mutations and could potentially benefit from this therapy.

"It turns out that STRC gene variations are more common than we thought which makes gene therapy for this disorder so important."

CLICK HERE TO GET THE FOX NEWS APP

The Boston team plans to investigate if the gene therapy technique works with the human stereocilin gene using human inner ear cells in a dish, derived from patients with STRC hearing loss. If it restores auditory function at the tissue level, the researchers hope to apply to the FDA for permission to test it in humans, according to the news release.

See more here:
Advanced gene therapy may reverse hearing loss caused by genetics: study - Fox News

Posted in Human Genetics | Comments Off on Advanced gene therapy may reverse hearing loss caused by genetics: study – Fox News

Could pollution, traffic, and fast food be affecting how many babies of each sex are born? – Fast Company

Posted: at 7:06 pm

Its classic Biology 101: A mother has two sex chromosomes, X and X, and a father has an X and a Y, and the combination in a new embryo determines the sex. So, statistically, there should be an equal number of newborn male and female babies in the world. But, in reality, there are slightly more boys than girls. According to World Bank data, the global sex ratio at birth (SRB) of males to females in a population stands at around 107:100.

In order to offer some explanations for this phenomenon, a team of scientists did a large-scale study, attempting to find associations between various societal and environmental factors for shifts in the SRB in both directions. They found that factors including chemical pollutants, food deserts, and crowdedness led to slight changes in SRB. They note these are only correlations, so more work has to be done to assess direct cause and effect, and to explain why it might be happening, biologically.

Sex is determined at conception, when parents chromosomes pair up in random fashion. So, its likely later, during pregnancy, when environmental factors could shape the fate of an embryo, says Andrey Rzhetsky, professor of medicine and human genetics at the University of Chicago, and one of the studys authors. Whether more male or female embryos die during gestationessentially, via miscarriagesprobably determines the SRB. Under different circumstances, embryos of one sex are dying more often, skewing the SRB one way or the other. Sex ratio is determined by the environment because some embryos are dying spontaneously, he says. And we dont know why.

Using national data, the team studied the entire Swedish population (about 9 million) over the course of 30 years, and half the U.S. population (about 150 million) over the course of 8. They tested 100 hypotheses, including environmental factors like the presence of mercury in water, lead in land, and air pollution particulates; and social factors, such as traffic, high renter-occupancy level, and negative food-related business, an EPA term denoting an areas higher prevalence of unhealthy eateries like fast-food restaurants, convenience stores, and pretzel trucks.

They found that some of the factors produced more male babies born compared to females, while others produced the opposite. For instance, pollutants like mercury in water and fine particulate matter in air were associated with more male babies, whereas lead in land correlated with more female babies. Extreme drought and traffic fatality rate were associated with males; high renter-occupancy level and fast-food prevalence with females. Within some groups tested, the researchers registered up to a 4% change in the SRB, which would equate to about 40,000 babies in a population of 1 million.

Rzhetsky notes that these are simply associations, not causes and effects. Still, he argues that they are more than coincidences, given that sex ratio consistently varies across the U.S. Without further work, he wont speculate much as to why, biologically, these changes happen. He says, its established that stress factors can cause termination, so its possible that a biological mechanism terminates a pregnancy under unfavorable factors, when high stress hormone levels are detected, to try and keep a mother safe.

Hes also open to a possibility, as other scientists have suggested, that the stress factors skew survival of gametes (the cells that come together to form an embryo) of one sex more than another, meaning that the environmental effects are happening before gestation. But, because the chromosome pairing is random, he thinks the miscarriage theory is more plausible. To ascertain more, and concrete, explanations, he recommends further work, probably with lab mice, or experiments with human cell tissuesboth embryos and gametes.

A notable, and perhaps surprising, finding from the study was that some factors, which scientists long thought would be prime drivers of sex ratio change, including changes of the seasons and of ambient temperatures, were not associated with SRB shifts. Nor were stressors such as violent crime and unemployment. But, Absence of proof is not proof of absence, Rzhetsky says, again recommending further study.

Here is the original post:
Could pollution, traffic, and fast food be affecting how many babies of each sex are born? - Fast Company

Posted in Human Genetics | Comments Off on Could pollution, traffic, and fast food be affecting how many babies of each sex are born? – Fast Company

Neurotheology : Is Your Brain Really Spiritual? – The Times of India Blog

Posted: at 7:06 pm

The most spiritually intense experiences of life have the capacity to momentarily withdraw a person from the realm of time and space. It is inevitable that people want to be in pursuit of spirituality that not only brings harmony and serenity within the soul but also enlightenment to the mind. Spirituality is the food for soul, soul craves it; and when unable to find it, looks for it in inebriated materials. Nonetheless, spirituality can be experienced by any human being irrespective of him/her being religious or profane. Scientists at the Yale University have unearthed the exact spot in human brain which activates when people experience spirituality. According to Marc Potenza, a psychiatry professor at Yale University, parietal cortex in human brain is the area associated with spirituality. Thus, neuropsychological connection with spirituality makes it not an unattainable feat to achieve and is also essential in knowing the brain functioning.

Spirituality, with its meaningful charisma, is culturally all-encompassing and inclusive. Religion, on the other hand, is more of an institutionalized entity. Transcendence, which is the ability to transcend ones own self, is also associated with spirituality. Similarly, enlightenment, according to Buddhist point of view, is the absence of suffering and desire, along with presence of absolute peace. Low stress and anxiety levels are observed among people who experience enlightenment. The reason lies in the decreased activity in frontal lobes, attained during meditation. 24/7 working frontal lobes, processing complex information and events all the time, when experience lower to none activity during meditation practice or prayer, delve into the realm of enlightenment where there is no stress, hassle or worry. Lower activity in frontal lobe is linked with the feelings of surrendering ones will completely, states Andrew Newberg, a neuroscientist, and the author of The Metaphysical Mind: Probing the Biology of Philosophical Thought. When our egoistic mind submits itself completely to something infinite and larger than itself, it experiences enlightenment.

The general perception regarding the attributes that genetically transfer from generation to generation is a lot complex to discuss in case of spirituality. Geneticists themselves admit of genes not telling every complex detail of human genetics. So, there still lacks data regarding religious and spiritual beliefs being transferred from parent to offspring. However Dr. Dean Hamer, author of the book The God Gene: How Faith is Hardwired into our Genes complements the gene variation in subjects who experience ecstatic and euphoric moments during spiritual activity. Still, the question whether spirituality is genetically transferred or not is debatable and needs further elucidation. On the other hand, neural substrate of human beings does support spirituality and beliefs. Our brain is designed to recognize God, because, if it doesnt, the suffering arises. We have God neurons deep in our limbic system (also linked with emotion), states Rhawn Joseph, a neurotheologian. The question then arises: can only theists have this neutral network in their brain to posses these god neurons? In Professor Jordan Grafmans words, There is nothing unique about religious belief in these brain structures. Religion doesnt have a God spot as such, instead its embedded in a whole range of other belief systems in the brain that we use everyday. According to my opinion, based on analysis, god neurons are present in everybody, theist or atheist, the key is to recognize and hit that particular spot that brings spirituality and enlightenment. One can experience spirituality or enlightenment through meditation practices. The focus needs to curb our 24/7 talking brain, which hassles to think about every problem there is. As the study suggests that a human thinks approximately 6200 thoughts per day. Not one, not two, 6200 thoughts. And meditation practices offer a chance to submerge into a no-thought brain. Hence, it is indubitable to say that our brains are hardwired to tap into the spiritual realm.

Religion has existed for centuries and peoples belief in the higher and ultimate authority has given them a sense of belonging and feeling of security. In US, 80% adults have a kind of religious or spiritual belief, according to a study published online in The Council on Recovery. People with no belief are usually seen to undergo existential crisis, lacking a sense of meaning and purpose. The hollowness, void and nothingness pervade the being; even the world itself appears purposeless. The raison dtre is their inability to identity the godneuron in their brains. It is not surprising then why people commit suicide out of agonizing stress and constant worry. The neurotheological study, therefore, is significant in elucidating concepts about the workings of the brain. Scholar Akshat Jain and his teams working in this area of Neuroscience to open few more gates.

This world is a trivial place to live in. Everyday worldly experiences can tire a brain to an excruciating level. Consequently, the modern world is fraught with innumerable cases of stress disorders. Our means of survival and meaningful living are highly dependent on spiritual experiences. They have a profound impacts on peoples lives, state researchers at Yale University. Religious people, gurus, monks, nuns, mediators; all of these peoples calmness and wherewithal to take this world and its problems flippantly, is because of their years of meditational practice. In James Allens words, Meditation is the secret of all growth in spiritual life and knowledge. Therefore the question is not whether your brain is spiritual of not, but have you tapped into your brain to make it spiritual. To conclude with a quote of Amit Ray, Suffering is due to disconnection with the inner soul, meditation is establishing that connection.

Views expressed above are the author's own.

END OF ARTICLE

Here is the original post:
Neurotheology : Is Your Brain Really Spiritual? - The Times of India Blog

Posted in Human Genetics | Comments Off on Neurotheology : Is Your Brain Really Spiritual? – The Times of India Blog

New gene therapy could provide cure for sickle cell disease, according to UAB study – The Mix

Posted: at 7:05 pm

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.New research fromUniversity of Alabama at Birmingham, published in theNew England Journal of Medicine, suggests a gene therapy called LentiGlobin could provide a permanent cure for sickle cell disease.

Julie Kanter, M.D., director of the UABAdult Sickle Cell Clinic, says patients treated with this therapy are beginning to show signs of producing stable amounts of normal red blood cells containing hemoglobin.

SCD occurs in about one out of every 365 Black or African American births, according to the Centers for Disease Control and Prevention, and about one in 13 Black or African American babies is born with sickle cell trait.

Kanter says there are several types of gene therapy (gene addition/transfer, gene editing, gene correction and gene silencing), but this particular therapy is gene addition or transfer.

In this therapy, we do not change or edit the gene that causes sickle cell disease, Kanter said. Instead, we use a viral vector to deliver a new gene that will make a healthy hemoglobin a beta hemoglobin into the stem cell. This is like coding new instructions into the cell.The old instructions for hemoglobin S are still there, but now the cell can make HbA and HbS. The vector can deliver more than one copy of the instructions to each cell usually between one and four copies so the cell can make moreHbA than HbS.

A vector is part of a virus. Kanter compares vectors to envelopes and letters.

I like to think of it as an envelope, she said. We take out the bad part of a virus (the letter) and leave the empty envelope. We put a new gene (the new letter) with the right instructions into the envelope and send it into the stem cells.The viral parts of the letter are removed so patients dont get the virus itself they only get the letter coding for the new hemoglobin, called HbAT87Q.

T87Q is a special type of hemoglobin A that is slightly different from regular hemoglobin A and has two advantages:

Kanter says that, although this therapy is providing a significant amount of hope, researchers continue to test to make sure the therapy remains safe.

In an earlier part of this study, we were not able to get enough of the new gene into each cell, Kanter said.Not enough envelopes were delivered.

This caused the stem cells to be extra stressed and the patients to still have some parts of sickle cell disease.They had only slight improvements compared to group C.

Unfortunately, the stressed-out cells are also more likely to make bad clones, which can cause cancer, she said.Two patients in group A developed leukemia because the cells were too stressed.

It is important to note that this was not caused by the viral vector or the new gene (not from the LentiGlobin) but from the stress of the procedure and the insufficient cell correction.

We need to see that we have fixed this problem in group C and no one else develops leukemia, Kanter said. We also need to make sure this procedure both reduces pain/stops all pain crisis and prevents organ damage from sickle cell.This will take time. We will have to watch people for the next two to 15 years and measure their organ function compared to those who did not get this therapy.

Much of Kanters career has been dedicated to helping those with SCD. A therapy like this is a game changer, according to Kanter.

It means a lot, she said.People with sickle cell disease have endured unnecessary hardship for more than 100 years. They have fewer medications and therapies than many other diseases and have received much less attention and funding. We need new and better options for people with sickle cell disease.

She also says this is just a beginning.

This therapy gives us hope and promise for a better future for those living with sickle cell disease.

We need to make these treatments available, and we need all people with sickle cell disease to have a sickle cell doctor to make that happen, she said. We need the therapy to be affordable so that people everywhere living with this disease have the option for gene therapy.Right now, most people with sickle cell disease live in sub-Saharan Africa and in India.They dont have even the basic treatments they need like vaccines, penicillin or hydroxyurea that can make a huge difference in peoples lives with SCD. Eventually we need people in these areas to have equal opportunity to better outcomes.

Visit link:
New gene therapy could provide cure for sickle cell disease, according to UAB study - The Mix

Posted in Gene Medicine | Comments Off on New gene therapy could provide cure for sickle cell disease, according to UAB study – The Mix

Durham gene therapy plant to help Pfizer develop treatments for rare diseases – WRAL Tech Wire

Posted: at 7:05 pm

DURHAM Drug giant Pfizer on Wednesday cut the ribbon on a new manufacturing facility in Durham that will focus on gene therapy treatments for various illnesses.

The $68.5 million, 85,500-square-foot plant near the intersection of Interstate 40 and Interstate 540 will be home to Pfizers BioTherapeutics Pharmaceutical Sciences group. More than 50 jobs will be created, said BethAnne Bort, the site lead and analytical research and development director, and another 40 will move from a Pfizer site in Chapel Hill.

This new facility delivers and provides our team with expanded capabilities and space to pioneer breakthroughs for our patients, Bort said.

Gene therapy is a form of medicine that involves delivering genes to targeted tissues in the body to produce missing or non-functioning proteins. Bort said that, by using genes as medicine, the underlying cause of a disease can be targeted at the cellular level, potentially with just one treatment.

Gene therapy represents the next wave of innovation for patients living with rare diseases, for whom there are limited treatment options currently available, Paul Mensah, vice president of BioTherapeutics Pharmaceutical Sciences, said in a statement. [The Durham plant] represents the next step in strengthening Pfizers in-house gene therapy capabilities and underscores the unique ability, expertise and resources we have to guide gene therapy through the entire development and manufacturing process and deliver this potentially life-changing technology to patients.

Pfizers current gene therapy portfolio includes three late-stage clinical programs for hemophilia A, hemophilia B and Duchenne muscular dystrophy, as well as 12 pre-clinical programs investigating potential treatments for rare cardiology, endocrine, hematology, metabolic and neurology diseases. One or two clinical studies on those treatments are expected to start each year.

Pfizer already has a major plant in Sanford that makes and tests various vaccines and gene therapy treatments.

From a diverse pool of talent to the presence of research universities, state leaders say the Triangle is the ideal place for biotech companies to set up shop.

Since 2017, gene therapy companies have invested more than $1 billion in North Carolina, state Commerce Secretary Machelle Sanders said.

Bill Bullock, senior vice president of the North Carolina Biotechnology Center, said the state has added more than 12,000 life science jobs in the last three years, and the momentum doesnt appear to be slowing down.

There are still dozens of companies actively looking at North Carolina all across the spectrum, from research and development to diagnostics to medical testing to manufacturing, Bullock said. Its a growth industry, and its here to stay.

Go here to see the original:
Durham gene therapy plant to help Pfizer develop treatments for rare diseases - WRAL Tech Wire

Posted in Gene Medicine | Comments Off on Durham gene therapy plant to help Pfizer develop treatments for rare diseases – WRAL Tech Wire

Page 577«..1020..576577578579..590600..»